Found: 5
Select item for more details and to access through your institution.
Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 326, doi. 10.1002/cpdd.203
- By:
- Publication type:
- Article
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 1, p. 117, doi. 10.1007/s00280-023-04634-4
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00868
- By:
- Publication type:
- Article
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.
- Published in:
- Peritoneal Dialysis International, 2020, v. 40, n. 4, p. 384, doi. 10.1177/0896860819889774
- By:
- Publication type:
- Article
Establishment of a Disease‐Drug Trial Model for Postmenopausal Osteoporosis: A Zoledronic Acid Case Study.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, p. S86, doi. 10.1002/jcph.1748
- By:
- Publication type:
- Article